Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Niloff

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reports|July 1, 1985
Recombinant leukocyte alpha interferon in advanced ovarian carcinomaJ M Niloff, R C Knapp, G Jones, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 1991
Relationship between obesity and uterine leiomyomataS A Shikora, J M Niloff, B R Bistrian, et al.
Cancer Research|March 1, 1984
Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomasT L Klug, R C Bast, J M Niloff, et al.
Cancer|April 1, 1988
Whole abdominal irradiation for tumors of the uterine corpusJ S Loeffler, E M Rosen, J M Niloff, et al.
Fertility and Sterility|May 1, 1986
Elevated serum concentrations of CA-125 in patients with advanced endometriosisR L Barbieri, J M Niloff, R C Bast, et al.
Obstetrics and Gynecology|August 29, 1998
Incidence and predictors of cervical dysplasia in patients with minimally abnormal Papanicolaou smearsM H Kobelin, C G Kobelin, L Burke, et al.
American Journal of Obstetrics and Gynecology|April 15, 1984
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixJ M Niloff, T L Klug, E Schaetzl, et al.
Gynecologic Oncology|July 1, 1990
Antigenic heterogeneity in human ovarian cancerW R Welch, J M Niloff, D Anderson, et al.
Obstetrics and Gynecology|May 1, 1986
CA 125 serum levels correlated with second-look operations among ovarian cancer patientsJ S Berek, R C Knapp, G D Malkasian, et al.
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reports|July 1, 1985
Recombinant leukocyte alpha interferon in advanced ovarian carcinomaJ M Niloff, R C Knapp, G Jones, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 1991
Relationship between obesity and uterine leiomyomataS A Shikora, J M Niloff, B R Bistrian, et al.
Cancer Research|March 1, 1984
Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomasT L Klug, R C Bast, J M Niloff, et al.
Cancer|April 1, 1988
Whole abdominal irradiation for tumors of the uterine corpusJ S Loeffler, E M Rosen, J M Niloff, et al.
Fertility and Sterility|May 1, 1986
Elevated serum concentrations of CA-125 in patients with advanced endometriosisR L Barbieri, J M Niloff, R C Bast, et al.
Obstetrics and Gynecology|August 29, 1998
Incidence and predictors of cervical dysplasia in patients with minimally abnormal Papanicolaou smearsM H Kobelin, C G Kobelin, L Burke, et al.
American Journal of Obstetrics and Gynecology|April 15, 1984
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixJ M Niloff, T L Klug, E Schaetzl, et al.
Gynecologic Oncology|July 1, 1990
Antigenic heterogeneity in human ovarian cancerW R Welch, J M Niloff, D Anderson, et al.
Obstetrics and Gynecology|May 1, 1986
CA 125 serum levels correlated with second-look operations among ovarian cancer patientsJ S Berek, R C Knapp, G D Malkasian, et al.
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Pageof 3